Selected research
Industry Research
Cetirizine Hydrochloride API Industry Research Report 2026
Market perspective
The global Cetirizine Hydrochloride API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cetirizine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cetirizine Hydrochloride API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cetirizine Hydrochloride API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cetirizine Hydrochloride API include Merck, Jiangsu Hengrui Medicine, Unichem Laboratories Ltd, Solara Active Pharma Sciences Ltd, LGM Pharma, Ipca Laboratories Ltd, Granules India Ltd and Avanscure Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cetirizine Hydrochloride API market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cetirizine Hydrochloride API Market by Company
Merck
Jiangsu Hengrui Medicine
Unichem Laboratories Ltd
Solara Active Pharma Sciences Ltd
LGM Pharma
Ipca Laboratories Ltd
Granules India Ltd
Avanscure Lifesciences
Cetirizine Hydrochloride API Segment by Type
Purity≥98%
Purity<98%
Cetirizine Hydrochloride API Segment by Application
Allergic Rhinitis
Allergic Conjunctivitis
Chronic Urticaria
Others
Cetirizine Hydrochloride API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cetirizine Hydrochloride API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cetirizine Hydrochloride API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cetirizine Hydrochloride API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cetirizine Hydrochloride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cetirizine Hydrochloride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cetirizine Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥98%
- Purity<98%
Applications
- Allergic Rhinitis
- Allergic Conjunctivitis
- Chronic Urticaria
- Others
Companies covered
- Merck
- Jiangsu Hengrui Medicine
- Unichem Laboratories Ltd
- Solara Active Pharma Sciences Ltd
- LGM Pharma
- Ipca Laboratories Ltd
- Granules India Ltd
- Avanscure Lifesciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cetirizine Hydrochloride API Market Size (2021-2032)
- 2.2.2 Global Cetirizine Hydrochloride API Sales (2021-2032)
- 2.2.3 Global Cetirizine Hydrochloride API Market Average Price (2021-2032)
- 2.3 Cetirizine Hydrochloride API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥98%
- 2.3.3 Purity<98%
- 2.4 Cetirizine Hydrochloride API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Allergic Rhinitis
- 2.4.3 Allergic Conjunctivitis
- 2.4.4 Chronic Urticaria
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cetirizine Hydrochloride API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cetirizine Hydrochloride API Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Cetirizine Hydrochloride API Revenue of Manufacturers (2021-2026)
- 3.4 Global Cetirizine Hydrochloride API Average Price by Manufacturers (2021-2026)
- 3.5 Global Cetirizine Hydrochloride API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cetirizine Hydrochloride API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cetirizine Hydrochloride API, Product Type & Application
- 3.8 Global Manufacturers of Cetirizine Hydrochloride API, Established Date
- 3.9 Global Cetirizine Hydrochloride API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Cetirizine Hydrochloride API Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Jiangsu Hengrui Medicine
- 4.2.1 Jiangsu Hengrui Medicine Company Information
- 4.2.2 Jiangsu Hengrui Medicine Business Overview
- 4.2.3 Jiangsu Hengrui Medicine Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Hengrui Medicine Cetirizine Hydrochloride API Product Portfolio
- 4.2.5 Jiangsu Hengrui Medicine Recent Developments
- 4.3 Unichem Laboratories Ltd
- 4.3.1 Unichem Laboratories Ltd Company Information
- 4.3.2 Unichem Laboratories Ltd Business Overview
- 4.3.3 Unichem Laboratories Ltd Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Unichem Laboratories Ltd Cetirizine Hydrochloride API Product Portfolio
- 4.3.5 Unichem Laboratories Ltd Recent Developments
- 4.4 Solara Active Pharma Sciences Ltd
- 4.4.1 Solara Active Pharma Sciences Ltd Company Information
- 4.4.2 Solara Active Pharma Sciences Ltd Business Overview
- 4.4.3 Solara Active Pharma Sciences Ltd Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Solara Active Pharma Sciences Ltd Cetirizine Hydrochloride API Product Portfolio
- 4.4.5 Solara Active Pharma Sciences Ltd Recent Developments
- 4.5 LGM Pharma
- 4.5.1 LGM Pharma Company Information
- 4.5.2 LGM Pharma Business Overview
- 4.5.3 LGM Pharma Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LGM Pharma Cetirizine Hydrochloride API Product Portfolio
- 4.5.5 LGM Pharma Recent Developments
- 4.6 Ipca Laboratories Ltd
- 4.6.1 Ipca Laboratories Ltd Company Information
- 4.6.2 Ipca Laboratories Ltd Business Overview
- 4.6.3 Ipca Laboratories Ltd Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ipca Laboratories Ltd Cetirizine Hydrochloride API Product Portfolio
- 4.6.5 Ipca Laboratories Ltd Recent Developments
- 4.7 Granules India Ltd
- 4.7.1 Granules India Ltd Company Information
- 4.7.2 Granules India Ltd Business Overview
- 4.7.3 Granules India Ltd Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Granules India Ltd Cetirizine Hydrochloride API Product Portfolio
- 4.7.5 Granules India Ltd Recent Developments
- 4.8 Avanscure Lifesciences
- 4.8.1 Avanscure Lifesciences Company Information
- 4.8.2 Avanscure Lifesciences Business Overview
- 4.8.3 Avanscure Lifesciences Cetirizine Hydrochloride API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Avanscure Lifesciences Cetirizine Hydrochloride API Product Portfolio
- 4.8.5 Avanscure Lifesciences Recent Developments
5 Global Cetirizine Hydrochloride API Market Scenario by Region
- 5.1 Global Cetirizine Hydrochloride API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cetirizine Hydrochloride API Sales by Region: 2021-2032
- 5.2.1 Global Cetirizine Hydrochloride API Sales by Region: 2021-2026
- 5.2.2 Global Cetirizine Hydrochloride API Sales by Region: 2027-2032
- 5.3 Global Cetirizine Hydrochloride API Revenue by Region: 2021-2032
- 5.3.1 Global Cetirizine Hydrochloride API Revenue by Region: 2021-2026
- 5.3.2 Global Cetirizine Hydrochloride API Revenue by Region: 2027-2032
- 5.4 North America Cetirizine Hydrochloride API Market Facts & Figures by Country
- 5.4.1 North America Cetirizine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 5.4.3 North America Cetirizine Hydrochloride API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cetirizine Hydrochloride API Market Facts & Figures by Country
- 5.5.1 Europe Cetirizine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 5.5.3 Europe Cetirizine Hydrochloride API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cetirizine Hydrochloride API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cetirizine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cetirizine Hydrochloride API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cetirizine Hydrochloride API Market Facts & Figures by Country
- 5.7.1 South America Cetirizine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 5.7.3 South America Cetirizine Hydrochloride API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cetirizine Hydrochloride API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cetirizine Hydrochloride API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cetirizine Hydrochloride API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cetirizine Hydrochloride API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cetirizine Hydrochloride API Sales by Type (2021-2032)
- 6.1.1 Global Cetirizine Hydrochloride API Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Cetirizine Hydrochloride API Sales Market Share by Type (2021-2032)
- 6.2 Global Cetirizine Hydrochloride API Revenue by Type (2021-2032)
- 6.2.1 Global Cetirizine Hydrochloride API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cetirizine Hydrochloride API Revenue Market Share by Type (2021-2032)
- 6.3 Global Cetirizine Hydrochloride API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cetirizine Hydrochloride API Sales by Application (2021-2032)
- 7.1.1 Global Cetirizine Hydrochloride API Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Cetirizine Hydrochloride API Sales Market Share by Application (2021-2032)
- 7.2 Global Cetirizine Hydrochloride API Revenue by Application (2021-2032)
- 7.2.1 Global Cetirizine Hydrochloride API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cetirizine Hydrochloride API Revenue Market Share by Application (2021-2032)
- 7.3 Global Cetirizine Hydrochloride API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cetirizine Hydrochloride API Value Chain Analysis
- 8.1.1 Cetirizine Hydrochloride API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cetirizine Hydrochloride API Production Mode & Process
- 8.2 Cetirizine Hydrochloride API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cetirizine Hydrochloride API Distributors
- 8.2.3 Cetirizine Hydrochloride API Customers
9 Global Cetirizine Hydrochloride API Analyzing Market Dynamics
- 9.1 Cetirizine Hydrochloride API Industry Trends
- 9.2 Cetirizine Hydrochloride API Industry Drivers
- 9.3 Cetirizine Hydrochloride API Industry Opportunities and Challenges
- 9.4 Cetirizine Hydrochloride API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst